• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Campbell’s fires exec accused of making racist comments

admin - Latest News - November 27, 2025
admin
7 views 6 secs 0 Comments



Campbell’s fires exec accused of making racist comments



Source link

TAGS:
PREVIOUS
Trump: Shooting suspect came to U.S. from Afghanistan
NEXT
Nov. 27, 2025, 12:32 AM ESTBy Phil Helsel and Jennifer JettPresident Donald Trump called for a “re-examination” of all Afghan nationals who came to the U.S. during the Biden administration, hours after an Afghan man was named as the suspect in the shooting of two National Guard members in Washington, D.C.Homeland Security Secretary Kristi Noem said on X that the suspect came to the U.S. in September 2021 under Operation Allies Welcome, a Biden-era program designed to help Afghans who assisted U.S. forces and were facing a Taliban takeover.“We must now re-examine every single alien who has entered our country from Afghanistan under Biden,” Trump said in an address Wednesday night in which he called the shooting an “act of terror.”Shortly after his remarks, U.S. Citizenship and Immigration Services said it was halting the processing of immigration from Afghanistan to the U.S.“Effective immediately, processing of all immigration requests relating to Afghan nationals is stopped indefinitely pending further review of security and vetting protocols,” the agency, known as USCIS, said on X.The two National Guard members, who are from West Virginia and deployed to Washington, were shot by a gunman around 2:15 p.m. They were in critical condition Wednesday, officials said. The suspect was also shot — by whom was still under investigation — and was hospitalized, according to police.Authorities have not detailed a motive, if one is known, but D.C. Mayor Muriel Bowser said that “this is a targeted shooting” and that the suspect appeared to target the guard members.The suspect has been identified as Rahmanullah Lakanwal, 29, of Bellingham, Washington, four senior law enforcement officials briefed on the investigation told NBC News.A relative of Lakanwal’s told NBC News on Wednesday that Lakanwal arrived in the U.S. in September 2021 after having served in the Afghan Army for 10 years, alongside U.S. Special Forces.Lakanwal was stationed at a base in Kandahar for part of that time, the relative said. He came to the U.S. after the Taliban returned to power following the August 2021 withdrawal of U.S.-led forces and eventually settled in Washington state.“We were the ones that were targeted by the Taliban in Afghanistan,” the relative said. “I cannot believe it that he might do this.”A source familiar with the case and a separate law enforcement source told NBC News that the suspect was granted asylum this year.Details of what a re-examination of Afghans already in the U.S. would look like, and who arrived during the Biden administration, were not immediately clear Wednesday night.A Trump administration memo on Friday, seen by NBC News on Tuesday, called for a review of all refugees admitted to the U.S. during the Biden administration — which could affect 200,000 people.The memo calls for a “comprehensive review and a re-interview of all refugees admitted from January 20, 2021, to February 20, 2025,” including U.S. green card holders. It cites a finding by USCIS that the Biden administration “potentially prioritized expediency, quantity, and admissions over quality interviews and detailed screening and vetting.”The San Diego-based Afghan advocacy group #AfghanEvac, which works to ensure that Afghans who helped the U.S. are not abandoned in the wake of the Taliban takeover, said Wednesday’s shooting should not be used to punish Afghans in the U.S.“Afghan immigrants and wartime allies who resettle in the United States undergo some of the most extensive security vetting of any population entering the country,” Shawn VanDiver, the group’s president, said in a statement.“This individual’s isolated and violent act should not be used as an excuse to define or diminish an entire community,” he added.The Department of Homeland Security resettled more than 80,000 Afghan refugees to the U.S. before or immediately after the U.S. withdrawal from Afghanistan and the subsequent takeover by the Taliban. But many others who wanted to leave were left behind.The State Department’s inspector general’s office said in a June 2023 report that as of March of that year, 152,091 Afghan “Special Immigrant Visa” applicants in Afghanistan were waiting on processing. The visa is for Afghans who were employed by or on behalf of the U.S.Afghan immigrants and refugees, including those who aided the American military during 20 years of war, have been all but barred from entering the U.S. during Trump’s second term.On his first day in office, Trump signed an executive order suspending all refugee resettlement in the U.S. until admissions align “with the interests of the United States.” Thousands of Afghan refugees, including many who had already been approved for U.S. resettlement, are stranded in Afghanistan, Pakistan and other countries, and in some cases they have been forcibly repatriated.The Trump administration has also terminated protections that allowed Afghans to live and work in the U.S. temporarily because of dangerous conditions at home. The White House says the protections are no longer needed because it is now safe to return to Afghanistan, which is experiencing multiple humanitarian crises and which Trump described as a “hellhole” in Wednesday’s address.Advocates say that Afghans who worked with the U.S. are at risk of persecution, torture or death if they return to Taliban-ruled Afghanistan and that they undergo extensive vetting before they arrive in the U.S.Trump has said he is committed to helping Afghans who worked with the U.S. military, saying in August that “we know the good ones and we know the ones that maybe aren’t so good.”Phil HelselPhil Helsel is a reporter for NBC News.Jennifer JettJennifer Jett is the Asia Digital Editor for NBC News, based in Hong Kong.Courtney Kube, Rich Schapiro, Abigail Williams, Laura Strickler and Tom Winter contributed.
Related Post
November 6, 2025
Demonstrators protest against opening of Shein store
October 5, 2025
Melania Trump gives Navy sailors a 'Hooyah!'
November 5, 2025
Newsom says Prop 50 win sends powerful message to Trump
November 8, 2025
Savewith a NBCUniversal ProfileCreate your free profile or log in to save this articleNov. 8, 2025, 5:00 AM ESTBy Mithil AggarwalNEW DELHI — When the weight loss drug Mounjaro came on the market in India earlier this year, Shyamanthak Kiran was one of the first patients to try it.Kiran, a 27-year-old financial trader who has struggled with hypothyroidism, said he “did not have a lot of expectations” when it came to losing weight. But “luck turned out in my favor,” he said, and in six months he lost all of the 60-plus pounds he had gained a few years earlier.“It was a two-year struggle that came to an end, and I couldn’t be happier,” he told NBC News.Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a country that has been called the world’s diabetes capital. The injectable medication from American pharmaceutical company Eli Lilly has become India’s most popular drug by value since being approved in March, with over $11 million in sales in October, pharmaceutical market research firm Pharmarack said Friday.Mounjaro is an injectable medication used to treat diabetes. Saumya Khandelwal for NBC NewsEven before India’s more recent approval of Ozempic, another drug that is widely used for weight loss in the United States and other countries, there was already surging demand in the country for semaglutide, its active ingredient.Ozempic’s Danish drugmaker, Novo Nordisk, says it is “actively working” to widen the availability of the drug, which Indian regulators have approved for diabetes but not obesity. The company also makes other semaglutide drugs that are already used for weight loss in India, including Wegovy, an injectable, and Rybelsus, which is taken orally.Demand could grow even further when the patent for Ozempic’s active ingredient, semaglutide, expires next March in India, a pharmaceutical manufacturing giant where companies are eager to produce cheaper generic versions of the lucrative weight-loss drugs.The exploding popularity of the drugs has taken aback some doctors and officials, with Jitendra Singh, a government minister and physician, warning in August against the “unchecked spread of disinformation” through “fad regimens” and emphasizing the importance of lifestyle interventions such as regular yoga practice.Semaglutide and tirzepatide, the active ingredient in Mounjaro, are GLP-1 agonists that were first developed to treat diabetes and have also been approved in many countries for the treatment of obesity. They regulate blood sugar and help slow how quickly food passes through the stomach, curbing hunger as a result.India, the world’s most populous country, has over 100 million people with diabetes, or nearly 10% of its adult population, according to a 2023 study by the Indian Council of Medical Research. An additional 135 million people are prediabetic, the study found.Diabetes information displayed on the walls of a clinic in New Delhi last month.Saumya Khandelwal for NBC NewsDoctors say the situation is worsening as India’s burgeoning middle class adopts a more Western lifestyle, eating more high-fat, high-sugar foods and exercising less.“Compared to, say, a decade ago, there are more people now in their late 20s and early 30s who are being diagnosed with diabetes, as compared to the elderly population,” said Dr. Saurav Shishir Agrawal, an endocrinologist in Noida, which is part of Delhi’s capital region.“They ask us to just give them pills,” Agrawal said, “but these medicines work better only when you are clubbing them with lifestyle changes.”Agrawal practices at the newly built Medanta Hospital, where staff greet patients with a gentle “Namaste.” It is an example of the growing number of modern and high-end hospitals popping up around increasingly dense megacities such as Delhi, home to 33 million people, where diabetes has a greater hold.Saurav Agrawal, an endocrinologist at Medanta Hospital in Noida, India.Saumya Khandelwal for NBC NewsA monthly course of Mounjaro can cost as much as $250, the average monthly salary in many parts of India. But for more affluent Indians, a bigger deterrent is the idea of injecting themselves, said Dr. Tribhuvan Gulati, an endocrinologist.“People get scared whenever you tell them that they’re going to be on an injectable,” said Gulati, who has a clinic in central Delhi.Gulati keeps a demo pen of Mounjaro in a drawer to show how easy it is to use the medicine, which just needs to be refrigerated before use.But the ease of use is also what worries Gulati and other doctors, who say many patients fail to overhaul the lifestyle and dietary habits causing or contributing to their health issues in the first place.“If you look at the causes of obesity in India, it is 90% lifestyle and 10% anything else,” said Dr. Anoop Misra, chairman of the Fortis Centre for Diabetes, Obesity and Cholesterol and head of India’s National Diabetes Obesity and Cholesterol Foundation.“The diet now is totally imbalanced because of free availability of food everywhere,” he said.The potential gastrointestinal and other side effects from the weight-loss drugs, which in the U.S. have prompted multiple lawsuits against GLP-1 makers, give some patients pause, Gulati said. But others “are OK with continuing it throughout their life because they know that they won’t be able to control themselves.”A handbook about managing diabetes at a clinic in New Delhi.Saumya Khandelwal for NBC NewsDiabetic patients such as Moinak Pal, who has high insulin resistance, say that GLP-1 drugs have been the easiest way to lose weight.“I have been fat-shamed since I was a child,” said Pal, 34, a Noida-based journalist. He said he has been losing about 3 pounds a week since he started taking Mounjaro.It was “extremely difficult for me to lose weight by conventional means,” he said.Part of the problem, Misra said, is the lifestyle in India’s sprawling and congested urban areas, where commutes can last as long as four hours round-trip. When workers get home, apps can deliver everything from food to clothes to their doorsteps in minutes.“They want quick fixes that don’t involve going on a restrictive diet or daily exercise of an hour and so on,” he said of some of his patients. “As a result, diabetes is everywhere. Every day I see patients who are young, who have uncontrolled Type 2 diabetes.”Rajendra Nath Dixit blames nobody but himself for his health problems. The retired banker had heart bypass surgery earlier this year, and before that had been spending almost 8,000 rupees ($90) a month just on his insulin.“I was fond of taking the typical Indian oily foods, samosas, chole bhature, and in the evening I would take five or six rotis,” said Dixit, 66. “Every bad habit was there.”In the five months since his surgery, Dixit has switched over completely to the oral semaglutide Rybelsus, is exercising more and is consuming less fat and sugar. He is spending 11,000 rupees ($125) a month on Rybelsus, but has been able to stop using insulin.“I’m feeling very good, very light,” he said. “My confidence has gone up, and my life has totally changed.”Mithil AggarwalMithil Aggarwal is a Hong Kong-based reporter/producer for NBC News.
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved